4.5 Review

Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia

Related references

Note: Only part of the references are listed.
Review Oncology

Chemical radiosensitizers for use in radiotherapy

P. Wardman

CLINICAL ONCOLOGY (2007)

Article Oncology

Identifying and targeting hypoxia in head and neck cancer: A brief overview of current approaches

Quynh-Thu Le

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Oncology

EF5 binding and clinical outcome in human soft tissue sarcomas

SM Evans et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker

MM Kleiter et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

Hypoxic cell turnover in different solid tumor lines

ASE Ljungkvist et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)

Article Oncology

HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors

HLK Janssen et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)